A025 A025 Pill - green capsule/oblong, 18mm
Pill with imprint A025 A025 is Green, Capsule/Oblong and has been identified as Amphetamine and Dextroamphetamine Extended-Release 25 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Amphetamine/dextroamphetamine is used in the treatment of ADHD; Narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Amphetamine/dextroamphetamine 25 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for A025 A025
Amphetamine and Dextroamphetamine Extended-Release
- Imprint
- A025 A025
- Strength
- 25 mg
- Color
- Green
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00480-3684
Related images for "A025 A025"
More about amphetamine / dextroamphetamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,159)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: CNS stimulants
- En español
Patient resources
- Amphetamine and dextroamphetamine drug information
- Dextroamphetamine and amphetamine (Advanced Reading)
- Dextroamphetamine and Amphetamine Tablets
- Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)
- Dextroamphetamine and Amphetamine Extended-Release Capsules (Mydayis)
Other brands
Adderall, Adderall XR, Mydayis
Professional resources
- Amphetamine monograph
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate (FDA)
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate ER Capsules (FDA)
Other brands
Adderall, Adderall XR, Mydayis
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
